Skip to main content
Log in

Local adipose tissue renin-angiotensin system

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

A local renin-angiotensin system (RAS) has been proposed in adipocytes. Adipocytes are a suggested source of components of the RAS, with regulation of their production related to obesity-hypertension. Both angiotensin type 1 and 2 receptors have been localized to adipocytes. Angiotensin II has been demonstrated to regulate adipocyte growth and differentiation, lipid metabolism, and expression and release of adipokines and RAS components, and to promote oxidative stress. Differences in regional expression of RAS components in visceral versus subcutaneous adipose tissue have been suggested as a link between abdominal obesity and cardiovascular disease. Finally, several studies support antihypertensive efficacy of RAS blockade in patients with type 2 diabetes and obesity. Future studies should address the role of adipocyte-specific deficiency of RAS components to definitively determine the relevance of the adipose RAS to normal physiology and to the development of hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Bays H, Rodbard HW, Schorr AB, Gonzalez-Campoy JM: Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk. Curr Treat Options Cardiovasc Med 2007, 9:259–271.

    Article  PubMed  Google Scholar 

  2. Cassis LA, Saye J, Peach MJ: Location and regulation of rat angiotensinogen messenger RNA. Hypertension 1988, 11:591–596.

    PubMed  CAS  Google Scholar 

  3. Campbell DJ, Habener JF: Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 1987, 121:1616–1626.

    PubMed  CAS  Google Scholar 

  4. Cassis LA, Lynch KR, Peach MJ: Localization of angiotensinogen messenger RNA in rat aorta. Circ Res 1988, 62:1259–1262.

    PubMed  CAS  Google Scholar 

  5. Cassis LA: Fat cell metabolism: insulin, fatty acids, and renin. Curr Hypertens Rep 2000, 2:132–138.

    Article  PubMed  CAS  Google Scholar 

  6. Lu H, Boustany-Kari CM, Daugherty A, Cassis LA: Angiotensin II increases adipose angiotensinogen expression. Am J Physiol Endocrinol Metab 2007, 292:E1280–E1287.

    Article  PubMed  CAS  Google Scholar 

  7. Kim S, Soltani-Bejnood M, Quignard-Boulange A, et al.: The adipose renin-angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal renin-angiotensin system. J Biomed Biotechnol 2006, 2006:27012.

    PubMed  Google Scholar 

  8. Goossens GH, Jocken JW, Blaak EE, et al.: Endocrine role of the renin-angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation. Hypertension 2007, 49:542–547.

    Article  PubMed  CAS  Google Scholar 

  9. Goossens GH, McQuaid SE, Dennis AL, et al.: Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humans. J Physiol 2006, 571:451–460.

    Article  PubMed  CAS  Google Scholar 

  10. Li Y, Jain S, Patil S, Kumar A: A haplotype of angiotensinogen gene that is associated with essential hypertension increases its promoter activity in adipocytes. Vascul Pharmacol 2006, 44:29–33.

    Article  PubMed  CAS  Google Scholar 

  11. Jain S, Tang X, Narayanan CS, et al.: Angiotensinogen gene polymorphism at-217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem 2002, 277:36889–36896.

    Article  PubMed  CAS  Google Scholar 

  12. Dickson ME, Zimmerman MB, Rahmouni K, Sigmund CD: The-20 and-217 promoter variants dominate differential angiotensinogen haplotype regulation in angiotensinogen-expressing cells. Hypertension 2007, 49:631–639.

    Article  PubMed  CAS  Google Scholar 

  13. Kotani K, Sakane N, Saiga K, et al.: The uncoupling protein-1 gene-3826A/G polymorphism and hypertension in Japanese subjects. Clin Chem Lab Med 2007, 45:1186–1189.

    Article  PubMed  CAS  Google Scholar 

  14. Achard V, Boullu-Ciocca S, Desbriere R, et al.: Renin receptor expression in human adipose tissue. Am J Physiol Regul Integr Comp Physiol, 2007, 292:R274–R282.

    PubMed  CAS  Google Scholar 

  15. Bujak-Gizycka B, Madej J, Wolkow PP, et al.: Measurement of angiotensin metabolites in organ bath and cell culture experiments by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS). J Physiol Pharmacol 2007, 58:529–540.

    PubMed  CAS  Google Scholar 

  16. Cassis L, Gupte M, Boustany C, et al.: Novel expression of ACE2 in adipose tissue and regulation by PPARγ ligands and by high fat diets [abstract CHBRPP142]. Paper presented at the Council for High Blood Pressure Research Conference. San Antonio, TX; October 4–7, 2006.

  17. Ailhaud G: Cross talk between adipocytes and their precursors: relationships with adipose tissue development and blood pressure. Ann N Y Acad Sci 1999, 892:127–133.

    Article  PubMed  CAS  Google Scholar 

  18. Brucher R, Cifuentes M, Acuna MJ, et al.: Larger anti-adipogenic effect of angiotensin II on omental preadipose cells of obese humans. Obesity (Silver Spring) 2007, 15:1643–1646.

    Article  CAS  Google Scholar 

  19. Skurk T, van Harmelen V, Hauner H: Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB. Arterioscler Thromb Vasc Biol 2004, 24:1199–1203.

    Article  PubMed  CAS  Google Scholar 

  20. Matsushita K, Wu Y, Okamoto Y, et al.: Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 2006, 48:1095–1102.

    Article  PubMed  CAS  Google Scholar 

  21. Sarzani R, Marcucci P, Salvi F, et al.: Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. Int J Obes (Lond) 2007, Epub ahead of print.

  22. Weisberg SP, McCann D, Desai M, et al.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796–1808.

    PubMed  CAS  Google Scholar 

  23. Xu H, Barnes GT, Yang Q, et al.: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821–1830.

    PubMed  CAS  Google Scholar 

  24. Daugherty A, Manning MW, Cassis LA: Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000, 105:1605–1612.

    Article  PubMed  CAS  Google Scholar 

  25. Harrison D, Griendling KK, Landmesser U, et al.: Role of oxidative stress in atherosclerosis. Am J Cardiol 2003, 91:7A–11A.

    Article  PubMed  CAS  Google Scholar 

  26. Tsuchiya K, Yoshimoto T, Hirono Y, et al.: Angiotensin II induces monocyte chemoattractant protein-1 expression via nuclear factor-kappa B-dependent pathway in rat preadipocytes. Am J Physiol Endocrinol Metab 2006, 291:E771–E778.

    Article  PubMed  CAS  Google Scholar 

  27. Kurata A, Nishizawa H, Kihara S, et al.: Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int 2006, 70:1717–1724.

    Article  PubMed  CAS  Google Scholar 

  28. Yvan-Charvet L, Bobard A, Bossard P, et al.: In vivo evidence for a role of adipose tissue SR-BI in the nutritional and hormonal regulation of adiposity and cholesterol homeostasis. Arterioscler Thromb Vasc Biol 2007, 27:1340–1345.

    Article  PubMed  CAS  Google Scholar 

  29. Iwai M, Chen R, Imura Y, Horiuchi M: TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation. Am J Hypertens 2007, 20:579–586.

    Article  PubMed  CAS  Google Scholar 

  30. Zorad S, Dou JT, Benicky J, et al.: Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma. Eur J Pharmacol 2006, 552:112–122.

    Article  PubMed  CAS  Google Scholar 

  31. Vague J: The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956, 4:20–34.

    PubMed  CAS  Google Scholar 

  32. Giacchetti G, Faloia E, Mariniello B, et al.: Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 2002, 15:381–388.

    Article  PubMed  CAS  Google Scholar 

  33. Shimabukuro M, Tanaka H, Shimabukuro T: Effects of telmisartan on fat distribution in individuals with the metabolic syndrome. J Hypertens 2007, 25:841–848.

    Article  PubMed  CAS  Google Scholar 

  34. Engeli S, Bohnke J, Gorzelniak K, et al.: Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005, 45:356–362.

    Article  PubMed  CAS  Google Scholar 

  35. Garg A, Fleckenstein JL, Peshock RM, Grundy SM: Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. J Clin Endocrinol Metab 1992, 75:358–361.

    Article  PubMed  CAS  Google Scholar 

  36. Abate N, Garg A: Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity. Prog Lipid Res 1995, 34:53–70.

    Article  PubMed  CAS  Google Scholar 

  37. Soltis EE, Cassis LA: Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens 1991, 13:277–296.

    Article  CAS  Google Scholar 

  38. Takemori K, Gao YJ, Ding L, et al.: Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. Hypertension 2007, 49:365–372.

    Article  PubMed  CAS  Google Scholar 

  39. Segura J, Ruilope LM: Obesity, essential hypertension and renin-angiotensin system. Public Health Nutr 2007, 10:1151–1155.

    Article  PubMed  Google Scholar 

  40. Kintscher U, Bramlage P, Paar WD, et al.: Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the treat to target post-authorization survey. Prospective observational, two armed study in 14,200 patients. Cardiovasc Diabetol 2007, 6:12.

    Article  PubMed  CAS  Google Scholar 

  41. Scholze J, Grimm E, Herrmann D, et al.: Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. Circulation 2007, 115:1991–1998.

    Article  PubMed  CAS  Google Scholar 

  42. Schindler C, Bramlage P, Thoenes M, et al.: Cardiovascular risk in obese hypertensive patients taking various antihypertensive drugs. Clin Drug Investig 2007, 27:707–717.

    Article  PubMed  CAS  Google Scholar 

  43. Bestermann W, Houston MC, Basile J, et al.: Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome. Am J Med Sci 2005, 329:292–305.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lisa A. Cassis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cassis, L.A., Police, S.B., Yiannikouris, F. et al. Local adipose tissue renin-angiotensin system. Current Science Inc 10, 93–98 (2008). https://doi.org/10.1007/s11906-008-0019-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-008-0019-9

Keywords

Navigation